Literature DB >> 23458383

A 6-day clinical pathway after a pancreaticoduodenectomy is feasible, safe and efficient.

Dustin M Walters1, Patrick McGarey, Damien J LaPar, Aimee Strong, Elizabeth Good, Reid B Adams, Todd W Bauer.   

Abstract

BACKGROUND: The utilization of post-operative clinical pathways leads to shorter hospital stays and decreased healthcare costs. This study evaluated patient outcomes after implementation of a 6-day discharge pathway after a pancreaticoduodenectomy.
METHODS: A post-operative clinical pathway was developed and implemented for patients undergoing a pancreaticoduodenectomy at the present institution aimed at discharge by post-operative day six. Patient charts were retrospectively reviewed to determine the rates of adherence to the pathway at each step, readmission and post-operative complications.
RESULTS: In total, 113 consecutive patients underwent a pancreaticoduodenectomy, receiving post-operative care under the clinical pathway guidelines. The median length of stay was 7 days (mode 6 days); 41% of patients were discharged by post-operative day six, 62% by day seven and 79% by day eight. In univariate analysis, delayed gastric emptying was associated with a delayed discharge after post-operative day six (P = 0.002). There were no post-operative deaths and 16% of patients required readmission within 30 days of discharge. In univariate analysis, obesity was the only variable associated with an increased rate of readmission (P < 0.001). DISCUSSION: Clinical pathway utilization after a pancreaticoduodenectomy allows a high percentage of patients to be discharged within a week and is associated with a low rate of readmission. Clinical pathway implementation allows for safe and efficient patient care.
© 2012 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2012        PMID: 23458383      PMCID: PMC3948533          DOI: 10.1111/hpb.12016

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  23 in total

1.  Evaluation of the International Study Group of Pancreatic Surgery definition of delayed gastric emptying after pancreatoduodenectomy in a high-volume centre.

Authors:  T Welsch; M Borm; L Degrate; U Hinz; M W Büchler; M N Wente
Journal:  Br J Surg       Date:  2010-07       Impact factor: 6.939

2.  One thousand consecutive pancreaticoduodenectomies.

Authors:  John L Cameron; Taylor S Riall; JoAnn Coleman; Kenneth A Belcher
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

3.  Initiation of a critical pathway for pancreaticoduodenectomy at an academic institution--the first step in multidisciplinary team building.

Authors:  Eugene P Kennedy; Ernest L Rosato; Patricia K Sauter; Laura M Rosenberg; Cataldo Doria; Ignazio R Marino; Karen A Chojnacki; Adam C Berger; Charles J Yeo
Journal:  J Am Coll Surg       Date:  2007-05       Impact factor: 6.113

4.  Incidence of pancreatic anastomotic failure and delayed gastric emptying after pancreatoduodenectomy in 507 consecutive patients: use of a web-based calculator to improve homogeneity of definition.

Authors:  Yasushi Hashimoto; L William Traverso
Journal:  Surgery       Date:  2009-12-16       Impact factor: 3.982

5.  Fast-track recovery programme after pancreatico- duodenectomy reduces delayed gastric emptying.

Authors:  G Balzano; A Zerbi; M Braga; S Rocchetti; A A Beneduce; V Di Carlo
Journal:  Br J Surg       Date:  2008-11       Impact factor: 6.939

Review 6.  Outcomes in pancreatic cancer surgery.

Authors:  Richard K Orr
Journal:  Surg Clin North Am       Date:  2010-04       Impact factor: 2.741

7.  [Experience of a cephalic pancreatoduodenectomy fast-track program].

Authors:  María Custodia Montiel Casado; Fernando Pardo Sánchez; Fernando Rotellar Sastre; Pablo Martí Cruchaga; Francisco J Alvarez Cienfuegos
Journal:  Cir Esp       Date:  2010-05-11       Impact factor: 1.653

8.  Fast track--different implications in pancreatic surgery.

Authors:  P O Berberat; H Ingold; A Gulbinas; J Kleeff; M W Müller; C Gutt; M Weigand; H Friess; M W Büchler
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

9.  Readmissions following pancreaticoduodenectomy for pancreas cancer: a population-based appraisal.

Authors:  Irina Yermilov; David Bentrem; Evan Sekeris; Sushma Jain; Melinda A Maggard; Clifford Y Ko; James S Tomlinson
Journal:  Ann Surg Oncol       Date:  2008-11-11       Impact factor: 5.344

10.  Fast Track THR: One Hospital's Experience with a 2-Day Length of Stay Protocol for Total Hip Replacement.

Authors:  Lawrence V Gulotta; Douglas E Padgett; Thomas P Sculco; Michael Urban; Stephen Lyman; Bryan J Nestor
Journal:  HSS J       Date:  2011-07-02
View more
  4 in total

1.  Implementation and Evaluation of a Clinical Pathway for Pancreaticoduodenectomy Procedures: a Prospective Cohort Study.

Authors:  Marion van der Kolk; Mark van den Boogaard; Femke Becking-Verhaar; Hettie Custers; Hans van der Hoeven; Peter Pickkers; Kees van Laarhoven
Journal:  J Gastrointest Surg       Date:  2017-06-06       Impact factor: 3.452

2.  High performing whipple patients: factors associated with short length of stay after open pancreaticoduodenectomy.

Authors:  Grace C Lee; Zhi Ven Fong; Cristina R Ferrone; Sarah P Thayer; Andrew L Warshaw; Keith D Lillemoe; Carlos Fernández-del Castillo
Journal:  J Gastrointest Surg       Date:  2014-08-05       Impact factor: 3.452

3.  Analysis of patient-dropouts from the critical pathways for gastric cancer.

Authors:  Sungsoo Kim; Young Sun Yoo; Jin Ha Kim; Young Don Min
Journal:  Ann Surg Treat Res       Date:  2015-05-14       Impact factor: 1.859

4.  Clinical Pathways For Pancreatic Surgery: Are They A Suitable Instrument For Process Standardization To Improve Process And Outcome Quality Of Patients Undergoing Distal And Total Pancreatectomy? - A Retrospective Cohort Study.

Authors:  Patrick Téoule; Laura Römling; Matthias Schwarzbach; Emrullah Birgin; Felix Rückert; Torsten J Wilhelm; Marco Niedergethmann; Stefan Post; Nuh N Rahbari; Christoph Reißfelder; Ulrich Ronellenfitsch
Journal:  Ther Clin Risk Manag       Date:  2019-10-01       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.